Please Wait
Applying Filters...
menu
    • menu
    Towa Pharmaceutical-PSE
    News
    Notice of Partial Revision of Basic Policy for the Development

    17 Mar 2025

    // PRESS RELEASE

    Acquired approval for manufacture & marketing generic drugs

    17 Feb 2025

    // PRESS RELEASE

    financial results for Q3 of the year ending March 31, 202

    13 Feb 2025

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Towa Pharmaceutical

    Contact Supplier

    Website

    euroPLX 88 Lisbon

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/prL_A0I4ZVQ
    Menu

    Towa Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Towa Pharmaceutical

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    GDUFA fees paid

    USA
    arrow
    euroPLX 88 Lisbon
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

    Paid in : 2025

    Towa Pharmaceutical

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Towa Pharmaceutical

    Business Address : Calle de Sant Marti, 75-97 M...

    FEI Number : 3003121577

    Country : Japan

    Paid in : 2025

    Towa Pharmaceutical

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow